365 related articles for article (PubMed ID: 31922295)
1. Early-Motor Phenotype Relates to Neuropsychiatric and Cognitive Disorders in Huntington's Disease.
Julayanont P; Heilman KM; McFarland NR
Mov Disord; 2020 May; 35(5):781-788. PubMed ID: 31922295
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing cognitive function in patients with Huntington's disease from China: A cross-sectional clinical study.
Cheng YF; Liu KC; Yang TM; Xiao Y; Jiang QR; Huang JX; Zhang S; Wei QQ; Ou RW; Li CY; Gu XJ; Burgunder JM; Shang HF
Brain Behav; 2023 Nov; 13(11):e3258. PubMed ID: 37849450
[TBL] [Abstract][Full Text] [Related]
4. The Neuropsychiatry of Huntington Disease-Like 2: A Comparison with Huntington's Disease.
Ferreira-Correia A; Krause A; Anderson DG
J Huntingtons Dis; 2020; 9(4):325-334. PubMed ID: 33044188
[TBL] [Abstract][Full Text] [Related]
5. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
6. A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease.
Vinther-Jensen T; Larsen IU; Hjermind LE; Budtz-Jørgensen E; Nielsen TT; Nørremølle A; Nielsen JE; Vogel A
Orphanet J Rare Dis; 2014 Jul; 9():114. PubMed ID: 25026978
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB;
J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898
[TBL] [Abstract][Full Text] [Related]
8. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
[TBL] [Abstract][Full Text] [Related]
9. Functional and cognitive capacity differ in dystonic motor subtypes when compared to choreatic and hypokinetic-rigid motor subtypes in Huntington's disease.
Achenbach J; von Hein SM; Saft C
Brain Behav; 2020 Aug; 10(8):e01704. PubMed ID: 32530575
[TBL] [Abstract][Full Text] [Related]
10. Bradykinesia in early Huntington's disease.
Sánchez-Pernaute R; Künig G; del Barrio Alba A; de Yébenes JG; Vontobel P; Leenders KL
Neurology; 2000 Jan; 54(1):119-25. PubMed ID: 10636136
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients.
Ruiz-Idiago J; Pomarol-Clotet E; Salvador R
Parkinsonism Relat Disord; 2023 Jan; 106():105228. PubMed ID: 36470173
[TBL] [Abstract][Full Text] [Related]
12. Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.
Jacobs M; Hart EP; van Zwet EW; Bentivoglio AR; Burgunder JM; Craufurd D; Reilmann R; Saft C; Roos RA;
J Neurol; 2016 Oct; 263(10):2080-5. PubMed ID: 27435968
[TBL] [Abstract][Full Text] [Related]
13. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning.
Reedeker N; Van Der Mast RC; Giltay EJ; Van Duijn E; Roos RA
Mov Disord; 2010 Aug; 25(11):1612-8. PubMed ID: 20629165
[TBL] [Abstract][Full Text] [Related]
14. Huntington's Disease: Premotor Phase.
Ramos ARS; Garrett C
Neurodegener Dis; 2017; 17(6):313-322. PubMed ID: 29073635
[TBL] [Abstract][Full Text] [Related]
15. Mental health symptoms among those affected by Huntington's disease: A cross-sectional study.
Gunn S; Dale M; Ovaska-Stafford N; Maltby J
Brain Behav; 2023 Apr; 13(4):e2954. PubMed ID: 36880126
[TBL] [Abstract][Full Text] [Related]
16. Intellectual Curiosity and Action Initiation are Subtypes of Apathy Affected in Huntington Disease Gene Expansion Carriers.
Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A
Cogn Behav Neurol; 2021 Dec; 34(4):295-302. PubMed ID: 34851867
[TBL] [Abstract][Full Text] [Related]
17. Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.
McAllister B; Gusella JF; Landwehrmeyer GB; Lee JM; MacDonald ME; Orth M; Rosser AE; Williams NM; Holmans P; Jones L; Massey TH;
Neurology; 2021 May; 96(19):e2395-e2406. PubMed ID: 33766994
[TBL] [Abstract][Full Text] [Related]
18. Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.
Ross CA; Pantelyat A; Kogan J; Brandt J
Mov Disord; 2014 Sep; 29(11):1351-8. PubMed ID: 25216368
[TBL] [Abstract][Full Text] [Related]
19. Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease.
Hart EP; Dumas EM; Schoonderbeek A; Wolthuis SC; van Zwet EW; Roos RA
Mov Disord; 2014 Mar; 29(3):320-6. PubMed ID: 24500841
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.
Kloos AD; Kegelmeyer DA; Fritz NE; Daley AM; Young GS; Kostyk SK
J Huntingtons Dis; 2017; 6(4):363-370. PubMed ID: 29254103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
